Medscape3d
CAC Scans, Statins, and Coaching Can Lower Plaque Volume. Does It Matter?
People with intermediate-risk scores on coronary artery calcium testing who received statins and intensive health coaching ...
Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs
Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with Boehringer Ingelheim to accelerate ...
Medscape5d
Colchicine for CV Reduction Splits Cardiologists After CLEAR SYNERGY
After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...
Fierce Biotech5d
Boehringer Ingelheim teams with Veeva to launch new R&D platform One Medicine
Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...
European Medical Journal6d
Nemolizumab in Moderate-to-Severe Atopic Dermatitis: Long-Term Safety and Efficacy and New Biomarker Insights
Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...
Contract Pharma6d
Cognizant and Boehringer Ingelheim Launch One Medicine Platform
The One Medicine Platform replaces 20+ legacy platforms—unifying medicinal development processes & data sources into a ...
Veeva, Boehringer Ingelheim partner to launch ‘One Medicine Platform’
Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...